The revenue stands at ₹1,625.96 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.37 per cent from ₹1,421.64 crore. This corresponds to a year-on-year *(YoY) growth of 24.82 per cent.
Operating Profit stands at ₹423.58 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.04 per cent from ₹333.41 crore. This corresponds to a year-on-year *(YoY) growth of 20.56 per cent.
PBDT stands at ₹491.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.18 per cent from ₹392.48 crore. This corresponds to a year-on-year *(YoY) growth of 31.92 per cent.
Profit Before Tax stands at ₹446.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.72 per cent from ₹347.11 crore. This corresponds to a year-on-year *(YoY) growth of 34.93 per cent.
Net Profit stands at ₹334.22 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.32 per cent from ₹266.70 crore. This represents a 30.89 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | -0.22% | -4.65% | -2.93% | -0.32% | 17.85% | 42.26% |
| Anthem Bioscienc | 2.53% | -0.45% | -6.29% | 17.73% | 21.11% | 14.33% |
| Ipca Labs. | -1.03% | -2.23% | -1.98% | 3.04% | 28.84% | 45.35% |
| Glaxosmi. Pharma | -0.62% | -4.15% | -10.31% | 2.45% | 4.89% | -8.66% |
| Emcure Pharma | 1.37% | -2.96% | -6.73% | 2.79% | 13.05% | 38.85% |
| Wockhardt | -1.65% | -8.58% | -4.79% | 6.18% | 45.25% | 43.44% |
| Sai Life | -1.23% | -5.68% | -4.59% | 15.98% | 49.66% | 72.00% |
Chairman & Non Executive Dir. : Mannalal B Agrawal
Vice Chairman & Executive Dire : Madhusudan B Agrawal
ED / MD / Promoter : Yogesh Agrawal
ED / WTD / Joint MD / Promoter : Rajesh M Agrawal
Independent Non Exe. Director : David Rasquinha
Independent Non Exe. Director : Rajesh Shashikant Dalal
Independent Non Exe. Director : Medha Joshi
Independent Non Exe. Director : Simi Thapar
Senior Vice President & CS : Gaurang Shah